©The Author(s) 2025.
World J Gastrointest Oncol. Nov 15, 2025; 17(11): 109375
Published online Nov 15, 2025. doi: 10.4251/wjgo.v17.i11.109375
Published online Nov 15, 2025. doi: 10.4251/wjgo.v17.i11.109375
Table 5 Intraoperative and postoperative adverse events, n (%)
| Parameters | Sevoflurane group (n = 103) | Propofol group (n = 101) | χ2 | P value |
| Intraoperative | ||||
| Body movement | 24 (23.3) | 34 (33.66) | 2.691 | 0.101 |
| Hypoxia | 3 (2.91) | 6 (5.94) | 0.507 | 0.476 |
| Postoperative | ||||
| Hypoxia | 3 (2.91) | 0 (0) | 1.314 | 0.252 |
| Agitation | 8 (7.77) | 8 (7.92) | 0.002 | 0.967 |
| Nausea | 29 (28.16) | 45 (44.55) | 5.933 | 0.015 |
| Vomiting | 12 (11.65) | 14 (13.86) | 0.224 | 0.636 |
| Pruritus | 14 (13.59) | 17 (13.59) | 0.415 | 0.519 |
| Hypotensive episode | 24 (23.3) | 14 (13.86) | 2.998 | 0.083 |
- Citation: Wang Z, Cheng JW, Yu KY. Short-term and long-term effects of sevoflurane inhalation vs propofol total intravenous anesthesia in gastrectomy for gastric cancer. World J Gastrointest Oncol 2025; 17(11): 109375
- URL: https://www.wjgnet.com/1948-5204/full/v17/i11/109375.htm
- DOI: https://dx.doi.org/10.4251/wjgo.v17.i11.109375